◼ Archived
Health
🔮 fades ✓
CRISPR makes prostate cancer vulnerable to immunotherapy
CRISPR editing turns immune‑cold prostate tumors into immunotherapy targets, sparking a new treatment direction.
Gene Editing
4 independently checked trend briefs about this subject, newest first.
What this Gene Editing timeline shows
headlinez.news detected 4 source-qualified news clusters connected to Gene Editing between July 4, 2026 and July 27, 2026. They span 3 newsroom categories and average 5.3 independent sources per brief.
This hub includes only briefs supported by at least four sources and passed by the site's verification gate. Raw or weak detections may exist but are excluded here. Topic matching is based on the entities and themes recorded with each brief; open a card to inspect its source links, publication time, verification label and velocity history. Read the methodology and editorial policy for the full rules.
◼ Archived
Health
🔮 fades ✓
Exclusive: A couple paid more than $800,000 for a gene-editing therapy for their daughter. She died, and it wasn’t made public
A report reveals the death of a 6-year-old child following an experimental gene-editing treatment in China that was not disclosed to the public.
◼ Archived
Science
🔮 fades ✓
30 years since Dolly the sheep was born, where is cloning technology at now?
Cloning’s 30th anniversary sparks debate: from Dolly’s legacy to today’s ethical and scientific frontiers
◼ Archived
Business
🔮 fades ✓
Scribe Therapeutics files for IPO in test of public appetite for earlier-stage biotechs
Biotech IPO test: Scribe Therapeutics targets $75M valuation amid early-stage investor scrutiny